Viking Therapeutics, Inc. SEC filings VKTX

Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.

Viking Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2026 —
10-Q Quarterly report Oct 29, 2026 Sep 30, 2026
8-K Current report
Results of operations
Oct 28, 2026 Oct 28, 2026
8-K Current report
Material agreement, New debt
Sep 28, 2026 Sep 23, 2026
424B5 Prospectus supplement Sep 25, 2026 —
424B5 Prospectus supplement Sep 25, 2026 —
FWP Free writing prospectus Sep 24, 2026 —
305B2 Application for designation of a new trustee Sep 24, 2026 —
424B5 Prospectus supplement Sep 23, 2026 —
424B5 Prospectus supplement Sep 23, 2026 —
8-K Current report
Other events
Sep 22, 2026 Sep 22, 2026
4 Insider transaction Aug 7, 2026 Aug 1, 2026
3 Initial insider ownership Aug 7, 2026 Aug 1, 2026
S-3ASR Automatic shelf registration Jul 30, 2026 —
4 Insider transaction Jul 29, 2026 Jul 28, 2026
4 Insider transaction Jul 29, 2026 Jul 28, 2026
4 Insider transaction Jul 29, 2026 Jul 28, 2026
10-Q Quarterly report Jul 29, 2026 Jun 30, 2026
144 Notice of proposed sale Jul 29, 2026 —
8-K Current report
Results of operations
Jul 29, 2026 Jul 29, 2026
144 Notice of proposed sale Jul 29, 2026 —
144 Notice of proposed sale Jul 29, 2026 —
4 Insider transaction Jun 3, 2026 Jun 1, 2026
3 Initial insider ownership Jun 3, 2026 Jun 1, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 19, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 30, 2026 —
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Results of operations
Apr 29, 2026 Apr 29, 2026
ARS Annual report to shareholders Apr 1, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 1, 2026 —
DEF 14A Proxy statement Apr 1, 2026 May 19, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
4 Insider transaction Mar 10, 2026 Mar 10, 2026
10-K Annual report Feb 11, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 11, 2026 Feb 11, 2026
4 Insider transaction Jan 26, 2026 Jan 12, 2026
3 Initial insider ownership Jan 26, 2026 Jan 12, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
4 Insider transaction Jan 5, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 5, 2026 —
144 Notice of proposed sale Jan 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 28, 2025 Oct 27, 2025
4 Insider transaction Oct 28, 2025 Oct 27, 2025
4 Insider transaction Oct 28, 2025 Oct 27, 2025
4 Insider transaction Oct 28, 2025 Oct 27, 2025
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 28, 2025 —
144 Notice of proposed sale Oct 27, 2025 —
10-Q Quarterly report Oct 23, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 22, 2025 Oct 22, 2025
8-K Current report
Regulation FD disclosure
Aug 19, 2025 Aug 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2025 —
10-Q Quarterly report Jul 23, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 23, 2025 Jul 23, 2025
4 Insider transaction Jul 3, 2025 Jul 2, 2025
4 Insider transaction Jul 3, 2025 Jul 2, 2025
4 Insider transaction Jul 3, 2025 Jul 2, 2025
144 Notice of proposed sale Jul 3, 2025 —
144 Notice of proposed sale Jul 3, 2025 —
144 Notice of proposed sale Jul 3, 2025 —
8-K Current report
Shareholder vote results
May 27, 2025 May 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 12, 2025 —
10-Q Quarterly report Apr 24, 2025 Mar 31, 2025
DEFA14A Additional proxy material Apr 23, 2025 —
DEFR14A Filing Apr 23, 2025 —
8-K Current report
Results of operations
Apr 23, 2025 Apr 23, 2025
8-K Current report
Auditor change, Other events
Apr 23, 2025 Apr 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 23, 2025 —
UPLOAD Letter from the SEC Apr 21, 2025 —
4 Insider transaction Apr 14, 2025 Apr 11, 2025
4/A Filing Apr 8, 2025 Mar 31, 2025
CORRESP Letter to the SEC Apr 8, 2025 —
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 May 20, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
UPLOAD Letter from the SEC Mar 31, 2025 —
8-K Current report
Material agreement, New debt, Other events
Mar 11, 2025 Mar 10, 2025
10-K Annual report Feb 26, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 5, 2025 Feb 5, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 4, 2025 —
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 3, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
4 Insider transaction Jan 6, 2025 Jan 2, 2025
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
144 Notice of proposed sale Jan 6, 2025 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
4 Insider transaction Nov 8, 2024 Nov 8, 2024
144 Notice of proposed sale Nov 8, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 4, 2024 —
8-K Current report
Regulation FD disclosure
Nov 4, 2024 Nov 4, 2024
4 Insider transaction Oct 28, 2024 Oct 28, 2024
144 Notice of proposed sale Oct 28, 2024 —
4 Insider transaction Oct 25, 2024 Oct 25, 2024
4 Insider transaction Oct 25, 2024 Oct 25, 2024
144 Notice of proposed sale Oct 25, 2024 —
144 Notice of proposed sale Oct 25, 2024 —
10-Q Quarterly report Oct 23, 2024 Sep 30, 2024
8-K Current report
Results of operations
Oct 23, 2024 Oct 23, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 18, 2024 —
4 Insider transaction Sep 20, 2024 Sep 20, 2024
4 Insider transaction Sep 20, 2024 Sep 20, 2024
144 Notice of proposed sale Sep 20, 2024 —
144 Notice of proposed sale Sep 20, 2024 —
4 Insider transaction Aug 22, 2024 Aug 21, 2024
4 Insider transaction Aug 22, 2024 Aug 21, 2024
144 Notice of proposed sale Aug 21, 2024 —
144 Notice of proposed sale Aug 21, 2024 —
4 Insider transaction Aug 19, 2024 Aug 19, 2024
4 Insider transaction Aug 19, 2024 Aug 19, 2024
144 Notice of proposed sale Aug 19, 2024 —
144 Notice of proposed sale Aug 19, 2024 —
4 Insider transaction Aug 14, 2024 Aug 14, 2024
144 Notice of proposed sale Aug 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Aug 7, 2024 —
4 Insider transaction Jul 31, 2024 Jul 29, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024
4 Insider transaction Jul 31, 2024 Jul 29, 2024
144 Notice of proposed sale Jul 30, 2024 —
144 Notice of proposed sale Jul 30, 2024 —
144 Notice of proposed sale Jul 30, 2024 —
10-Q Quarterly report Jul 24, 2024 Jun 30, 2024
8-K Current report
Results of operations
Jul 24, 2024 Jul 24, 2024
8-K Current report
Regulation FD disclosure
Jun 4, 2024 Jun 4, 2024
8-K Current report
Officer or director change, Shareholder vote results
May 23, 2024 May 21, 2024
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 23, 2024 —
S-8 POS Filing May 22, 2024 —
S-8 Employee stock plan registration May 22, 2024 —
4 Insider transaction May 3, 2024 May 3, 2024
144 Notice of proposed sale May 3, 2024 —
4 Insider transaction May 2, 2024 May 1, 2024
144 Notice of proposed sale May 1, 2024 —
10-Q Quarterly report Apr 25, 2024 Mar 31, 2024
8-K Current report
Results of operations
Apr 24, 2024 Apr 24, 2024
ARS Annual report to shareholders Apr 5, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 5, 2024 —
DEF 14A Proxy statement Apr 5, 2024 May 21, 2024
4 Insider transaction Mar 27, 2024 Mar 27, 2024
4 Insider transaction Mar 27, 2024 Mar 27, 2024
4 Insider transaction Mar 27, 2024 Mar 27, 2024
8-K Current report
Regulation FD disclosure
Mar 26, 2024 Mar 26, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
4 Insider transaction Mar 4, 2024 Mar 1, 2024
8-K Current report
Other events
Mar 4, 2024 Mar 4, 2024
424B5 Prospectus supplement Mar 1, 2024 —
8-K Current report
Material agreement, Other events
Mar 1, 2024 Feb 28, 2024
424B5 Prospectus supplement Feb 27, 2024 —
8-K Current report
Regulation FD disclosure
Feb 27, 2024 Feb 27, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
4 Insider transaction Feb 9, 2024 Feb 9, 2024
144 Notice of proposed sale Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Feb 8, 2024 Feb 8, 2024
4 Insider transaction Feb 8, 2024 Feb 8, 2024
144 Notice of proposed sale Feb 8, 2024 —
144 Notice of proposed sale Feb 8, 2024 —
S-8 Employee stock plan registration Feb 7, 2024 —
10-K Annual report Feb 7, 2024 Dec 31, 2023
8-K Current report
Results of operations
Feb 7, 2024 Feb 7, 2024
4 Insider transaction Jan 31, 2024 Jan 31, 2024
144 Notice of proposed sale Jan 31, 2024 —
4 Insider transaction Jan 30, 2024 Jan 30, 2024
144 Notice of proposed sale Jan 30, 2024 —
SC 13G Ownership over 5% (passive) Jan 26, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 24, 2024 —
4 Insider transaction Jan 19, 2024 Jan 19, 2024
144 Notice of proposed sale Jan 19, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jan 12, 2024 —
4 Insider transaction Jan 4, 2024 Jan 3, 2024
4 Insider transaction Jan 4, 2024 Jan 3, 2024
4 Insider transaction Jan 4, 2024 Jan 3, 2024
4 Insider transaction Jan 4, 2024 Jan 2, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
VKTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
San Diego, CA
SEC filer status
Large accelerated filer
SEC CIK
1607678

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.